| abstract |
The present invention relates, at least in part, to novel substituted tetracycline compounds. For the treatment of many tetracycline compound responsive states such as bacterial infections and neoplasms, and for the general application of other known minocycline and tetracycline compounds, such as blocking tetracycline efflux and modulating gene expression These tetracycline compounds can be used. |